Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to 0.24%.

  • Harmony Biosciences Holdings' Return on Capital Employed changed 0.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.26% for FY2024, which is 700.0% down from last year.
  • Harmony Biosciences Holdings' Return on Capital Employed amounted to 0.24% in Q3 2025, which was down 0.0% from 0.25% recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Return on Capital Employed registered a high of 0.3% during Q4 2023, and its lowest value of 0.11% during Q1 2021.
  • In the last 5 years, Harmony Biosciences Holdings' Return on Capital Employed had a median value of 0.24% in 2025 and averaged 0.24%.
  • In the last 5 years, Harmony Biosciences Holdings' Return on Capital Employed surged by 1800bps in 2021 and then tumbled by -700bps in 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Return on Capital Employed (Quarter) stood at 0.24% in 2021, then fell by -15bps to 0.21% in 2022, then soared by 47bps to 0.3% in 2023, then dropped by -21bps to 0.24% in 2024, then dropped by 0bps to 0.24% in 2025.
  • Its last three reported values are 0.24% in Q3 2025, 0.25% for Q2 2025, and 0.23% during Q1 2025.